FDA Draft Guidance Recommends Boxed Warning for Breast Implants



DOCUMENTS
  • Draft Guidance


WASHINGTON, D.C. — The Food and Drug Administration has recommended a boxed warning for saline and silicone gel-filled breast implants, which would caution doctors and patients of the risk of breast implant-associated anaplastic large cell lymphoma.

In an Oct. 24 draft guidance, the agency says the boxed warning should also state that “breast implants are not considered lifetime devices; the chance of developing complications increases over time; and some complications will require more surgery.

The FDA also suggested including in the devices’ information booklet a patient decision checklist highlighting key information regarding risks. The agency says the body of …






UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: Acetaminophen ASD/ADHD Product Liability Litigation

October 21, 2022

MORE DETAILS



HarrisMartin's MDL Conference: The Current Mass Tort Landscape - Best Management Practices & Updates on Key Litigation

September 28, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS